Pharmacological and surgical therapy for primary postpartum hemorrhage

Current Pharmaceutical Design

Volumn 11, Issue 6, 2005, Pages 759-773

  Bouwmeester, F W ^a,b   Bolte, A C ^a,b   van Geijn, H P ^a,b  

^a Waterlandziekenhuis ^*  (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atony; Balloon tamponade; Postpartum hemorrhage; Recombinant activated factor VII; Tranexamic acid

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CARBOPROST; ERGOMETRINE PLUS OXYTOCIN; ERGOT ALKALOID; ERGOTAMINE; HEMOSTATIC AGENT; HEPARIN; LIVER ENZYME; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIC AGENT; OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN; SODIUM CHLORIDE; SULPROSTONE; THROMBIN; TRANEXAMIC ACID; UNINDEXED DRUG; UTEROTONIC AGENT; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ARTERY CATHETERIZATION; ARTERY LIGATION; ARTIFICIAL EMBOLISM; BLOOD TRANSFUSION; BRADYCARDIA; CESAREAN SECTION; CLINICAL TRIAL; COMPRESSION THERAPY; DEVASCULARIZATION; DIARRHEA; DRUG ABSORPTION; DRUG EXCRETION; DRUG FATALITY; DRUG MECHANISM; DRUG METABOLISM; DRUG MILK LEVEL; DRUG RESPONSE; DYSTOCIA; EMERGENCY SURGERY; FEVER; FLUID THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPOTENSION; HYSTERECTOMY; INCIDENCE; LUNG ARTERIOVENOUS SHUNT; MASSAGE; MATERNAL MORTALITY; MEDICAL CARE; MORBIDITY; NAUSEA; PLACENTA ACCRETA; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; REPRODUCTION; REVIEW; SHIVERING; SURGICAL TECHNIQUE; SUTURING METHOD; THROMBOEMBOLISM; VOMITING;

ADULT; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 14844313637     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612053381882     Document Type: Review

References (172)

1. Hill K, AbouZhar C, Wardlaw T. Estimates of maternal mortality for 1995. Bull World Health Organ 2001; 79: 182-193.
2. New estimates of maternal mortality. Wkly Epidemiol Rec 1996; 71: 97-100.
3. Drife J. Management of primary postpartum haemorrhage. Br J Obstet Gynaecol 1997; 104: 275-277.
4. Lewis G, Drife J. Why mothers die. A report on confidential enquiries into maternal deaths in the United Kingdom 1994-1996. 1998. London, HMSO.
5. Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol 2003; 101: 289-296.
6. Abouzahr C, Royston E. Global mortality: global factbook. 1991. Geneva, World Health Organisation.
7. Mousa HA, Walkinshaw S. Major postpartum haemorrhage. Curr Opin Obstet Gynecol 2001; 13: 595-603.
8. World Health Organisation. The prevention and management of postpartum haemorrhage. WHO report of technical working group. 1990. Geneva, World Health Organisation.
9. ACOG educational bulletin. Postpartum hemorrhage. Int J Gynaecol Obstet 1998; 61: 79-86.
10. Combs CA, Murphy EL, Laros Jr RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991; 77: 69-76.
11. Hypovolemic shock. In: Clark SL, Cotton DB, Hankins GD, Phelan JP, editors. Critical Care Obstetrics. Malden: Blackwell Science, 1997: 412-422.
12. Bonnar J. Massive obstetric haemorrhage, Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 1-18.
13. Hofmeyr GJ, Mohlala BK. Hypovolaemic shock. Best Pract Res Clin Obstet Gynaecol 2001; 15: 645-662.
14. Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993; 48: 15-18.
15. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001; 322: 1089-1093.
16. Brant HA. Precise estimation of postpartum haemorrhage: difficulties and importance. Br Med J 1967; 1: 398-400.
17. Shevell T, Malone FD. Management of obstetric hemorrhage. Semin Perinatol 2003; 27: 86-104.
18. Combs CA, Murphy EL, Laros Jr RK. Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol 1991; 77: 77-82.
19. Pregnancy-Induced Physiologic Alterations. In: Clark SL, Cotton DB, Hankins GD, Phelan JP, editors. Critical Care Obstetrics. Malden: Blackwell Science 1997; 3-32.
20. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Oxford: Update Software.
21. Salomon LJ, De Tayrac R, Castaigne-Meary V, Audibert F, Musset D, Ciorascu R, et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum Reprod 2003; 18: 849-852.
22. Nizard J, Barrinque L, Frydman R, Fernandez H. Fertility and pregnancy outcomes following hypogastric artery ligation for severe post-partum haemorrhage. Hum Reprod 2003; 18: 844-848.
23. Krapp M, Katalinic A, Smrcek J, Geipel A, Berg C, Germer U, et al. Study of the third stage of labor by color Doppler sonography. Arch Gynecol Obstet 2003; 267: 202-204.
24. Maymon R, Herman A, Halperin R, Bukovsky I, Weinraub Z, Ariely S. Changes in uterine artery Doppler flow velocity waveforms during the third stage of labor. Gynecol Obstet Invest 1995; 40: 24-27.
25. Herman A, Zimerman A, Arieli S, Tovbin Y, Bezer M, Bukovsky I, et al. Down-up sequential separation of the placenta. Ultrasound Obstet Gynecol 2002; 19: 278-281.
26. Krapp M, Baschat AA, Hankeln M, Gembruch U. Gray scale and color Doppler sonography in the third stage of labor for early detection of failed placental separation. Ultrasound Obstet Gynecol 2000; 15: 138-142.
27. Wenham J, Matijevic R. Post-partum hysterectomies: revisited. J Perinat Med 2001; 29: 260-265.
28. Zelop CM, Harlow BL, Frigoletto FD, Jr., Safon LE, Saltzman DH. Emergency peripartum hysterectomy. Am J Obstet Gynecol 1993; 168: 1443-1448.
29. Jauniaux E, Toplis PJ, Nicolaides KH. Sonographic diagnosis of a non-previa placenta accreta. Ultrasound Obstet Gynecol 1996; 7: 58-60.
30. Levine D, Hulka CA, Ludmir J, Li W, Edelman RR. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology 1997; 205: 773-776.
31. Levine D, Barnes PD, Edelman RR. Obstetric MR imaging. Radiology 1999; 211: 609-617.
32. Polvi H, Pirhonen J, Makinen J, Hirvonen T, Erkkola R. Postpartum diagnosis of placenta accreta with colour Doppler sonography. Ann Chir Gynaecol Suppl 1994; 208: 100-102.
33. de Vries JI, van der Linden RM, van der Linden HC. Predictive value of sonographic examination to visualize retained placenta directly after birth at 16 to 28 weeks. J Ultrasound Med 2000; 19: 7-12.
34. Cunningham FG, MacDonald PC, Gant NF. Williams Obstetrics. 20th ed. Norwalk Connecticut: Appleton-Century-Crofts, 1997.
35. Prendiville WJ, Elbourne D. Care during the third stage of labour. In: Chalmers I, Enkin E, Keirse MJ, editors. Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press 1989; 1145-1170.
36. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Oxford: Update Software.
37. Khan GQ, John IS, Chan T, Wani S, Hughes AO, Stirrat GM. Abu Dhabi third stage trial: oxytocin versus Syntometrine in the active management of the third stage of labour. Eur J Obstet Gynecol Reprod Biol 1995; 58: 147-151.
38. McDonald SJ, Prendiville WJ, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour. BMJ 1993; 307: 1167-1171.
39. Prendiville WJ. The prevention of post partum haemorrhage: optimising routine management of the third stage of labour. Eur J Obstet Gynecol Reprod Biol 1996; 69: 19-24.
40. Soriano D, Dulitzki M, Schiff E, Barkai G, Mashiach S, Seidman DS. A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1996; 103: 1068-1073.
41. Yuen PM, Chan NS, Yim SF, Chang AM. A randomised double blind comparison of Syntometrine and Syntocinon in the management of the third stage of labour. Br J Obstet Gynaecol 1995; 102: 377-380.
42. Hogerzeil HV, Walker GJ. Instability of (methyl)ergometrine in tropical climates: an overview. Eur J Obstet Gynecol Reprod Biol 1996; 69: 25-29.
43. Bivins HA Jr, Cope DA, Newman RB, Eller DP. Randomized trial of intraumbilical vein oxytocin in midtrimester pregnancy losses. Am J Obstet Gynecol 1993; 169: 1070-1073.
44. Makkonen M, Suonio S, Saarikoski S. Intraumbilical oxytocin for management of retained placenta. Int J Gynaecol Obstet 1995; 48: 169-172.
45. Ozcan T, Sahin G, Senoz S. The effect of intraumbilical oxytocin on the third stage of labour. Aust NZJ Obstet Gynaecol 1996; 36: 9-11.
46. Gazvani MR, Luckas MJ, Drakeley AJ, Emery SJ, Alfirevic Z, Walkinshaw SA. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial. Obstet Gynecol 1998; 91: 203-207.
47. Porter KB, O'Brien WF, Collins MK, Givens P, Knuppel R, Bruskivage L. A randomized comparison of umbilical vein and intravenous oxytocin during the puerperium. Obstet Gynecol 1991; 78: 254-256.
48. Young SB, Martelly PD, Greb L, Considine G, Coustan DR. The effect of intraumbilical oxytocin on the third stage of labor. Obstet Gynecol 1988; 71: 736-738.
49. Carroli G, Bergel E. Umbilical vein injection for management of retained placenta. (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Oxford: Update Software.
50. Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001; 358: 689-695.
51. Villar J, Gulmezoglu AM, Hofmeyr GJ, Forna F. Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecol 2002; 100: 1301-1312.
52. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review). In: The Cochrane Library, Issue 1, 2004; Oxford: Update Software.
53. Caliskan E, Dilbaz B, Meydanli MM, Ozturk N, Narin MA, Haberal A. Oral misoprostol for the third stage of labor: a randomized controlled trial. Obstet Gynecol 2003; 101: 921-928.
54. Oboro VO, Tabowei TO. A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour. J Obstet Gynaecol 2003; 23: 13-16.
55. Alvarez M, Lockwood CJ, Ghidini A, Dottino P, Mitty HA, Berkowitz RL. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol 1992; 9: 441-444.
56. Hansch E, Chitkara U, McAlpine J, El Sayed Y, Dake MD, Razavi MK. Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 1999; 180: 1454-1460.
57. Mitty HA, Sterling KM, Alvarez M, Gendler R. Obstetric hemorrhage: prophylactic and emergency arterial catheterization and embolotherapy. Radiology 1993; 188: 183-187.
58. Ledee N, Ville Y, Musset D, Mercier F, Frydman R, Fernandez H. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur J Obstet Gynecol Reprod Biol 2001; 94: 189-196.
59. Cottier JP, Fignon A, Tranquart F, Herbreteau D. Uterine necrosis after arterial embolization for postpartum hemorrhage. Obstet Gynecol 2002; 100: 1074-1077.
60. Vedantham S, Goodwin SC, McLucas B, Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol 1997; 176: 938-948.
61. Eltabbakh GH, Watson JD. Postpartum hysterectomy. Int J Gynaecol Obstet 1995; 50: 257-262.
62. Hayashi RH, Castillo MS, Noah ML. Management of severe postpartum hemorrhage with a prostaglandin F2 alpha analogue. Obstet Gynecol 1984; 63: 806-808.
63. Gibb DM. Comon Obstetric Emergencies. Oxford: Butterworth-Heineman, 1991.
64. Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol 1997; 177: 1071-1078.
65. Bigrigg A, Chissell S, Read MD. Use of intra myometrial 15-methyl prostaglandin F2 alpha to control atonic postpartum haemorrhage following vaginal delivery and failure of conventional therapy. Br J Obstet Gynaecol 1991; 98: 734-736.
66. Buttino L Jr, Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage. Am J Perinatol 1986; 3: 241-243.
67. Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol 1990; 162: 205-208.
68. Barrington JW, Roberts A. The use of gemeprost pessaries to arrest postpartum haemorrhage. Br J Obstet Gynaecol 1993; 100: 691-692.
69. Kupferminc MJ, Gull I, Bar-Am A, Daniel Y, Jaffa A, Shenhav M, et al. Intrauterine irrigation with prostaglandin F2-alpha for management of severe postpartum hemorrhage. Acta Obstet Gynecol Scand 1998; 77: 548-550.
70. Peyser MR, Kupferminc MJ. Management of severe postpartum hemorrhage by intrauterine irrigation with prostaglandin E2. Am J Obstet Gynecol 1990; 162: 694-696.
71. Heyl PS, Stubblefield PG, Phillippe M. Recurrent inversion of the puerperal uterus managed with 15(s)-15-methyl prostaglandin F2 alpha and uterine packing. Obstet Gynecol 1984; 63: 263-264.
72. Roberts WE. Emergent obstetric management of postpartum hemorrhage. Obstet Gynecol Clin North Am 1995; 22: 283-302.
73. Kilpatrick AW, Thorburn J. Severe hypotension due to intramyometrial injection of prostaglandin E2. Anaesthesia 1990; 45: 848-849.
74. Hankins GD, Berryman GK, Scott Jr RT, Hood D. Maternal arterial desaturation with 15-methyl prostaglandin F2 alpha for uterine atony. Obstet Gynecol 1988; 72: 367-370.
75. O'Brien P, El Refaey H, Gordon A, Geary M, Rodeck CH. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998; 92: 212-214.
76. Abdel-Aleem H, El Nashar I, Abdel-Aleem A. Management of severe postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2001; 72: 75-76.
77. Adekanmi OA, Purmessur S, Edwards G, Barrington JW. Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage. BJOG 2001; 108: 541-542.
78. Oboro VO, Tabowei TO, Bosah JO. Intrauterine misoprostol for refractory postpartum hemorrhage. Int J Gynaecol Obstet 2003; 80: 67-68.
79. Ozan H, Bilgin T, Ozsarac N, Ozerkan K, Cengiz C. Misoprostol in uterine atony: a report of 2 cases. Clin Exp Obstet Gynecol 2000; 27: 221-222.
80. Shojai R, Piechon L, d'Ercole C, Boubli L, Ponties JE. Rectal administration of misoprostol for delivery induced hemorrhage. Preliminary study. J Gynecol Obstet Biol Reprod (Paris) 2001; 30: 572-575.
81. Lokugamage AU, Sullivan KR, Niculescu I, Tigere P, Onyangunga F, El Refaey H, et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstet Gynecol Scand 2001; 80: 835-839.
82. Khan RU, El Refaey H. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol 2003; 101: 968-974.
83. Abdel-Aleem H, Villar J, Gulmezoglu AM, Mostafa SA, Youssef AA, Shokry M, et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2003; 108: 25-28.
84. Dall P, Pfisterer J, du BA, Wilhelm C, Pfleiderer A. Therapeutic strategies in cervical pregnancy. Eur J Obstet Gynecol Reprod Biol 1994; 56: 195-200.
85. Lurie S, Mamet Y. Transient myocardial ischemia may occur following subendometrial vasopressin infiltration. Eur J Obstet Gynecol Reprod Biol 2000; 91: 87-89.
86. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002; 32 Suppl 1: 41-46.
87. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003; 361: 201-205.
88. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion 2002; 42: 114-124.
89. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542-547.
90. Monroe DM, Hoffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost 2000; 26: 373-377.
91. Laffan MA, Cummins M. Recombinant factor VIIa for intractable surgical bleeding. Blood 2000; 96: 85b.
92. White B, O'Connor H, Smith OP. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency. Blood Coagul Fibrinolysis 2000; 11: 155-157.
93. De Leo V, Ditto A, Morgante G, La Marca A, Massafra C, Guidoni CG. Prophylactic therapy in a pregnant woman with severe factor VII deficiency. Gynecol Obstet Invest 2000; 50: 275-277.
94. Eskandari N, Feldman N, Greenspoon JS. Factor VII deficiency in pregnancy treated with recombinant factor VIIa. Obstet Gynecol 2002; 99: 935-937.
95. Jimenez-Yuste V, Villar A, Morado M, Canales M, Hernandez MC, Sanjurjo MJ, et al. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia 2000; 6: 588-590.
96. Muleo G, Santoro R, Iannaccaro PG, Papaleo P, Leo F. The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies. Blood Coagul Fibrinolysis 1998; 9: 389-390.
97. Bell JA, Savidge GF. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost 2003; 9: 167-170.
98. Monte S, Lyons G. Peripartum management of a patient with Glanzmann's thrombasthenia using Thrombelastograph. Br J Anaesth 2002; 88: 734-738.
99. Moscardo F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br 3 Haematol 2001; 114: 174-176.
100. Bouwmeester FW, Jonkhoff AR, Verheijen RH, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003; 101: 1174-1176.
101. Breborowicz GH, Sobieszczyk S, Szmankiewicz M. Efficacy of recombinant activated factor VII (rFVIIA, NovoSeven®) in prenatal medicine. Arch Perinat Med 2002; 8: 21-27.
102. Sobieszczyk S, Breborowicz GH, Markwitz W, Mallinger S, Adamski D, Kruszynski Z. Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy. Ginekol Pol 2002; 73: 230-233.
103. Sokolic V, Bukovic D, Fures R, Zadro M, Scuric I, Colak F, et al. Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after caesarean section - a case report. Coll Antropol 2002; 26 Suppl: 155-157.
104. Zupancic SS, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M. Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol 2002; 108: 162-163.
105. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-1032.
106. Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 1993; 70: 238-240.
107. As AK, Hagen P, Webb JB. Tranexamic acid in the management of postpartum haemorrhage. Br J Obstet Gynaecol 1996; 103: 1250-1251.
108. Corr P. Arterial embolization for haemorrhage in the obstetric patient. Best Pract Res Clin Obstet Gynaecol 2001; 15: 557-561.
109. Oei SG, Kho SN, ten Broeke ED, Brolmann HA. Arterial balloon occlusion of the hypogastric arteries: a life-saving procedure for severe obstetric hemorrhage. Am J Obstet Gynecol 2001; 185: 1255-1256.
110. O'Leary JA. Uterine artery ligation in the control of postcesarean hemorrhage. J Reprod Med 1995; 40: 189-193.
111. O'Leary JL, O'Leary JA. Uterine artery ligation in the control of intractable postpartum hemorrhage. Am J Obstet Gynecol 1966; 94: 920-924.
112. Waters EG. Surgical management of postpartum hemorrhage with particular reference to ligation of uterine arteries. Am J Obstet Gynecol 1952; 64: 1143-1148.
113. Farrell E. Save a life, make a difference: a solution for a bloody problem. Obstetric haemorrhage management guidelines. The Medicine Journal 2002; 44.
114. Burchell RC. Physiology of internal iliac artery ligation. J Obstet Gynaecol Br Commonw 1968; 75: 642-651.
115. Clark SL, Phelan JP, Yeh SY, Bruce SR, Paul RH. Hypogastric artery ligation for obstetric hemorrhage. Obstet Gynecol 1985; 66: 353-356.
116. Evans S, McShane P. The efficacy of internal iliac artery ligation in obstetric hemorrhage. Surg Gynecol Obstet 1985; 160: 250-253.
117. Cruikshank SH. Management of postpartum and pelvic hemorrhage. Clin Obstet Gynecol 1986; 29: 213-219.
118. AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994; 171: 694-700.
119. Eastman NJ. Anomalies of the third stage of labor. In: Eastman NJ, editor. Williams' Obstetrics. New York: Appleton-Century-Crofts, 1950: 917-919.
120. Maier RC. Control of postpartum hemorrhage with uterine packing. Am J Obstet Gynecol 1993; 169: 317-321.
121. Hsu S, Rodgers B, Lele A, Yeh J. Use of packing in obstetric hemorrhage of uterine origin. J Reprod Med 2003; 48: 69-71.
122. Druzin ML. Packing of lower uterine segment for control of postcesarean bleeding in instances of placenta previa. Surg Gynecol Obstet 1989; 169: 543-545.
123. Jouppila P. Postpartum haemorrhage. Curr Opin Obstet Gynecol 1995; 7: 446-450.
124. Chan C, Razvi K, Tham KF, Arulkumaran S. The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. Int J Gynaecol Obstet 1997; 58: 251-252.
125. Fahy U, Sved A, Burke G. Successful balloon tamponade of post cesarean hysterectomy pelvic bleeding: a case report. Acta Obstet Gynecol Scand 2003; 82: 97-98.
126. Katesmark M, Brown R, Raju KS. Successful use of a Sengstaken-Blakemore tube to control massive postpartum haemorrhage. Br J Obstet Gynaecol 1994; 101: 259-260.
127. Bakri YN. Uterine tamponade-drain for hemorrhage secondary to placenta previa-accreta. Int J Gynaecol Obstet 1992; 37: 302-303.
128. De Loor JA, van Dam PA. Foley catheters for uncontrollable obstetric or gynecologic hemorrhage. Obstet Gynecol 1996; 88: 737.
129. Marcovici I, Scoccia B. Postpartum hemorrhage and intrauterine balloon tamponade. A report of three cases. J Reprod Med 1999; 44: 122-126.
130. Johanson R, Kumar M, Obhrai M, Young P. Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG 2001; 108: 420-422.
131. Danso D, Reginald P. Combined B-lynch suture with intrauterine balloon catheter triumphs over massive postpartum haemorrhage. BJOG 2002; 109: 963.
132. Bakri YN, Amri A, Abdul JF. Tamponade-balloon for obstetrical bleeding. Int J Gynaecol Obstet 2001; 74: 139-142.
133. Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The "tamponade test" in the management of massive postpartum hemorrhage. Obstet Gynecol 2003; 101: 767-772.
134. Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol 1997; 104: 372-375.
135. Dacus JV, Busowski MT, Busowski JD, Smithson S, Masters K, Sibai BM. Surgical treatment of uterine atony employing the B-Lynch technique. J Matern Fetal Med 2000; 9: 194-196.
136. Ferguson JE, Bourgeois FJ, Underwood PB. B-Lynch suture for postpartum hemorrhage. Obstet Gynecol 2000; 95: 1020-1022.
137. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstet Gynecol 2002; 99: 502-506.
138. Mazhar SB, Yasmin S, Gulzar S. Management of massive postpartum hemorrhage by "B-Lynch" brace suture. J Coll Physicians Surg Pak 2003; 13: 51-52.
139. Smith KL, Baskett TF. Uterine compression sutures as an alternative to hysterectomy for severe postpartum hemorrhage. J Obstet Gynaecol Can 2003; 25: 197-200.
140. Vangsgaard K. "B-Lynch suture" in uterine atony. Ugeskr Laeger 2000; 162: 3468.
141. Wergeland H, Alagic E, Lokvik B. Use of the B-Lynch suture technique in postpartum hemorrhage. Tidsskr Nor Laegeforen 2002; 122: 370-372.
142. Tamizian O, Arulkumaran S. The surgical management of post-partum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2002; 16: 81-98.
143. Cho JH, Jun HS, Lee CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol 2000; 96: 129-131.
144. Chen CP, Chang TY, Yeh LF, Lin CJ, Wang W. Sonographic appearance of the uterus after simple square suturing for rapid control of postpartum hemorrhage and preservation of fertility. J Clin Ultrasound 2002; 30: 189-191.
145. Ochoa M, Allaire AD, Stitely ML. Pyometria after hemostatic square suture technique. Obstet Gynecol 2002; 99: 506-509.
146. McGuinness TB, Jackson JR, Schnapf DJ. Conservative surgical management of placental implantation site hemorrhage. Obstet Gynecol 1993; 81: 830-831.
147. Riggs JC, Jahshan A, Schiavello HJ. Alternative conservative management of placenta accreta. A case report. J Reprod Med 2000; 45: 595-598.
148. Karam AK, Bristow RE, Bienstock J, Montz FJ. Argon beam coagulation facilitates management of placenta percreta with bladder invasion. Obstet Gynecol 2003; 102: 555-556.
149. Scarantino SE, Reilly JG, Moretti ML, Pillari VT. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol 1999; 94: 825-827.
150. Lurie S, Gur D, Glezerman M. Argon beam coagulation during caesarean section. BJOG 2002; 109: 1415.
151. Bai SW, Lee HJ, Cho JS, Park YW, Kim SK, Park KH. Peripartum hysterectomy and associated factors. J Reprod Med 2003; 48: 148-152.
152. Chanrachakul B, Chaturachinda K, Phuapradit W, Roungsipragam R. Cesarean and postpartum hysterectomy. Int J Gynaecol Obstet 1996; 54: 109-113.
153. Engelsen IB, Albrechtsen S, Iversen OE. Peripartum hysterectomy-incidence and maternal morbidity. Acta Obstet Gynecol Scand 2001; 80: 409-412.
154. Ogunniyi SO, Esen UI. Obstetric hysterectomy in Ile-Ife, Nigeria. Int J Gynaecol Obstet 1990; 32: 23-27.
155. Okogbenin SA, Gharoro EP, Otoide VO, Okonta PI. Obstetric hysterectomy: fifteen years' experience in a Nigerian tertiary centre. J Obstet Gynaecol 2003; 23: 356-359.
156. Sheiner E, Levy A, Katz M, Mazor M. Identifying risk factors for peripartum cesarean hysterectomy. A population-based study. J Reprod Med 2003; 48: 622-626.
157. Wong WC, Kun KY, Tai CM. Emergency obstetric hysterectomies for postpartum haemorrhage. J Obstet Gynaecol Res 1999; 25: 425-430.
158. Yamani Zamzami TY. Indication of emergency peripartum hysterectomy: review of 17 cases. Arch Gynecol Obstet 2003; 268: 131-135.
159. Castaneda S, Karrison T, Cibils LA. Peripartum hysterectomy. J Perinat Med 2000; 28: 472-481.
160. Cesarean Section and Cesarean Hysterectomy. In: Hirsch HA, Käser O, Iklé FA, editors. Atlas of Gynecologic Surgery. New York: Thieme 1997; 165-180.
161. Plauche WC. Cesarean hysterectomy: indications, technique, and complications. Clin Obstet Gynecol 1986; 29: 318-328.
162. O'Leary JA. Pregnancy following uterine artery ligation. Obstet Gynecol 1980; 55: 112-113.
163. Pirard C, Squifflet J, Gilles A, Donnez J. Uterine necrosis and sepsis after vascular embolization and surgical ligation in a patient with postpartum hemorrhage. Fertil Steril 2002; 78: 412-413.
164. Goldberg J, Pereira L, Berghella V. Pregnancy after uterine artery embolization. Obstet Gynecol 2002; 100: 869-872.
165. Ryu RK, Chrisman HB, Omary RA, Miljkovic S, Nemcek AA, Jr., Saker MB, et al. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation. J Vasc Interv Radiol 2001; 12: 1071-1074.
166. Chrisman HB, Saker MB, Ryu RK, Nemcek Jr. AA, Gerbie MV, Milad MP, et al. The impact of uterine fibroid embolization on resumption of menses and ovarian function. J Vasc Interv Radiol 2000; 11: 699-703.
167. van Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 2001; 20: 15-23.
168. Tourne G, Collet F, Seffert P, Veyret C. Place of embolization of the uterine arteries in the management of post-partum haemorrhage: a study of 12 cases. Eur J Obstet Gynecol Reprod Biol 2003; 110: 29-34.
169. Hall MH, Halliwell R, Carr-Hill R. Concomitant and repeated happenings of complications of the third stage of labour. Br J Obstet Gynaecol 1985; 92: 732-738.
170. Armstead WM. Endothelins and the role of endothelin antagonists in the management of posttraumatic vasospasm. Curr Pharm Design 2004; 10(18): 2185-92.
171. Hertelendy F, Zakar T. Regulation of myometrial smooth muscle functions. Curr Pharm Design 2004; 10(20): 2499-517.
172. Maul H, Longo M, Saade GR, Garfield RE. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Design 2003; 9(5): 359-80.